1. Impact of Site Selection and Study Conduct on Outcomes in Global Clinical Trials

   • Chaudhry M. S. Sarwar
   • Muthiah Vaduganathan
   • Javed Butler

   Clinical Trials (J Butler, Section Editor) 24 June 2017 Pages: 203 - 209

   

2. Novel Endpoints for Heart Failure Clinical Trials

   • Carine E. Hamo
   • Mihai Gheorghiade
   • Javed Butler

   Clinical Trials (J Butler, Section Editor) 24 June 2017 Pages: 210 - 216

3. Designing Future Clinical Trials in Heart Failure With Preserved Ejection Fraction: Lessons From TOPCAT

   • Ravi B. Patel
   • Sanjiv J. Shah
   • Muthiah Vaduganathan

   Clinical Trials (J Butler, Section Editor) 24 June 2017 Pages: 217 - 222

4. Towards Holistic Heart Failure Management—How to Tackle the Iron Deficiency Epidemic?

   • Lucas N. L. Van Aelst
   • Dominiek Mazure
   • Alain Cohen-Solal

   Comorbidities of Heart Failure (C Angermann & F Edelmann, Section Editors) 01 July 2017 Pages: 223 - 234

   

5. From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities

   • Navin Suthahar
   • Wouter C. Meijers
   • Rudolf A. de Boer

   Comorbidities of Heart Failure (C Angermann & F Edelmann, Section Editors) Open access 13 July 2017 Pages: 235 - 250

   

6. Inflammation – Cause or Consequence of Heart Failure or Both?

   • Sophie Van Linthout
   • Carsten Tschöpe

   Comorbidities of Heart Failure (C Angermann and F Edelmann, Section Editors) Open access 30 June 2017 Pages: 251 - 265

   

7. Treatment of Hyperkalemia in Heart Failure

   • Ersilia M. DeFilippis
   • Akshay S. Desai

   Pathophysiology of Myocardial Failure (Inder Anand and Maria Patarroyo-Aponte, Section Editors) 27 June 2017 Pages: 266 - 274

8. Role of SGLT2 Inhibitors in Patients with Diabetes Mellitus and Heart Failure

   • Frederik H. Verbrugge

   Pharmacologic Therapy (W H W Tang, Section Editor) 24 June 2017 Pages: 275 - 283

   

9. Biomarkers in Sleep Apnea and Heart Failure

   • Ying Y. Zhao
   • Reena Mehra

   Biomarkers of Heart Failure (W.H.W. Tang and J.L. Grodin, Section Editors) 30 June 2017 Pages: 284 - 300

   

10. Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population

    • Kamal Shemisa
    • Anish Bhatt
    • Ian J. Neeland

    Biomarkers of Heart Failure (W.H.W. Tang and J.L. Grodin, Section Editors) 21 June 2017 Pages: 301 - 310

    

11. The Basic Metabolic Profile in Heart Failure—Marker and Modifier

    • Ahmed Elfar
    • Kamalanathan K. Sambandam

    Biomarkers of Heart Failure (W.H.W. Tang and J.L. Grodin, Section Editors) 03 July 2017 Pages: 311 - 320

    

12. Therapeutic Strategies Targeting Inherited Cardiomyopathies

    • Kenneth Varian
    • W. H. Wilson Tang

    Pharmacologic Therapy (W H W Tang, Section Editor) 28 June 2017 Pages: 321 - 330

13. SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys

    • Frederik H. Verbrugge
    • Pieter Martens
    • Wilfried Mullens

    Pathophysiology of Myocardial Failure (Inder Anand and Maria Patarroyo-Aponte, Section Editors) 30 June 2017 Pages: 331 - 337

    

14. Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure

    • Alexander Dietl
    • Christoph Maack

    Experimental Therapeutics (L.S. Maier, Section Editor) 27 June 2017 Pages: 338 - 349